Pediatric research
Screening and diagnosis of metabolic dysfunction-associated steatotic liver disease in children within public healthcare.
Lyydia Lahtinen, Pauliina Hiltunen, Nina Vuorela, Heini Huhtala, Kalle Kurppa, Linnea Aitokari
Published: 202510.1038/s41390-025-04540-w
Abstract
BACKGROUND: Metabolic dysfunction-associated steatotic liver disease (MASLD) has increased rapidly. NASPGHAN recommends screening children at risk for MASLD, but its implementation remains unclear. We explored the implementation of screening in healt…
Preview only. Read the full abstract at the source